“Billionaire Israel Englander Pours Money Into 2 “Strong Buy” Stocks”
November 30, 2020
“G1 Therapeutics (GTHX)…
Are other analysts in agreement? They are. Only Buy ratings, 3 to be exact, have been issued in the last three months. Therefore, the message is clear: GTHX is a Strong Buy. Given the $59 average price target, shares could rise 312% in the next year…
Epizyme (EPZM)…
Most other analysts echo Nierengarten’s sentiment. 3 Buys and 1 Hold add up to a Strong Buy consensus rating. With an average price target of $23.25, the upside potential comes in at 91%…”
https://finance.yahoo.com/news/billionaire-israel-englander-pours-money-173037588.html